CVE:WMD - WeedMD Stock Price, News & Analysis

Today's Range N/A
50-Day Range
MA: C$1.58
52-Week Range N/A
Volume313,711 shs
Average Volume544,525 shs
Market CapitalizationC$182.03 million
P/E RatioN/A
Dividend YieldN/A
WeedMD Inc. produces and sells medical marijuana, including dried marijuana, cannabis oil, cannabis resin, marijuana plants, and marijuana seeds in Canada. The company has a research and development supply and collaboration agreement with Revive Therapeutics Ltd. The company is headquartered in Aylmer, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesC$10.15 million
Book ValueC$0.72 per share



Market CapC$182.03 million
Next Earnings Date8/27/2019 (Estimated)
OptionableNot Optionable

Receive WMD News and Ratings via Email

Sign-up to receive the latest news and ratings for WMD and its competitors with MarketBeat's FREE daily newsletter.

WeedMD (CVE:WMD) Frequently Asked Questions

What is WeedMD's stock symbol?

WeedMD trades on the Canadian Venture Exchange (CVE) under the ticker symbol "WMD."

How were WeedMD's earnings last quarter?

WeedMD Inc (CVE:WMD) released its quarterly earnings results on Thursday, May, 30th. The company reported ($0.02) EPS for the quarter. The firm earned $3.69 million during the quarter. View WeedMD's Earnings History.

When is WeedMD's next earnings date?

WeedMD is scheduled to release their next quarterly earnings announcement on Tuesday, August 27th 2019. View Earnings Estimates for WeedMD.

Has WeedMD been receiving favorable news coverage?

Media headlines about WMD stock have trended positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. WeedMD earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for WeedMD.

Who are some of WeedMD's key competitors?

What other stocks do shareholders of WeedMD own?

Who are WeedMD's key executives?

WeedMD's management team includes the folowing people:
  • Mr. Keith Merker, CEO & Director (Age 46)
  • Dr. Luc C. Duchesne, Chief Scientific Officer (Age 58)
  • Mr. Bruce Dawson-Scully, Advisor (Age 45)
  • Ms. Nichola Thompson, Chief Financial Officer
  • Dr. Alexandre Sibilev, Vice-Pres of Quality Assurance & Global Regulatory Compliance

How do I buy shares of WeedMD?

Shares of WMD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is WeedMD?

WeedMD has a market capitalization of C$0.00 and generates C$10.15 million in revenue each year. WeedMD employs 135 workers across the globe.View Additional Information About WeedMD.

What is WeedMD's official website?

The official website for WeedMD is

How can I contact WeedMD?

WeedMD's mailing address is 320 Bay St Suite 1600, TORONTO, ON M5H 4A6, Canada. The company can be reached via phone at +1-416-5153923.

MarketBeat Community Rating for WeedMD (CVE WMD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  96 (Thanks for Voting!)
Underperform Votes:  75 (Thanks for Voting!)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about WeedMD and other stocks. Vote "Outperform" if you believe WMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by Staff

Featured Article: Lock-Up Period Expiration

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel